Imaging study for low-grade glioma in children and adults
Part of Brain & nervous system, Cancer clinical trials.
This study is testing how to take faster, better brain images in people diagnosed with low-grade glioma (a type of brain tumor). Better imaging may help doctors see the tumor more clearly while reducing time spent in the scanner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with low-grade glioma (LGG)
- If you’re an LGG patient: you receive care at DFCI
- You must be able to safely have MRI/brain imaging (no unsafe metal inside the body or near the eye)
- You should not have any implanted electrical devices, like a pacemaker or perfusion pump
- You should not have ferromagnetic (magnet-sensitive) implants or metal fragments
- If you can become pregnant: you cannot be trying to become pregnant, breastfeeding, or think you might be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests how well a special PET-MRI scan (using a radioactive tracer) can find and measure low-grade brain tumors. It may help doctors better track these tumors while you start or continue treatment.
This trial uses special imaging to tell the difference between real brain tumor growth and a treatment reaction that looks like a tumor. It may help you and your doctor decide if a biopsy is needed.
This study tests whether imaging scans can be timed based on your symptoms and progress, rather than on a fixed schedule. The goal is to make monitoring easier while keeping you safe during standard brain cancer treatment.
This Phase 1 study uses special MRI scans (including a form of MR spectroscopy) to better understand lower-grade gliomas. It is designed to test how well the imaging can “characterize” the tumor and to improve understanding for treatment planning.
This study uses a special MRI scan called CEST to look at low-grade brain tumors. It may help doctors learn more about these tumors without needing as many invasive tests. You may join if you have a low-grade glioma and haven't needed treatment yet.
This early-phase study uses a special PET scan plus MRI to help doctors tell apart tumor changes in children with aggressive gliomas. It may help find whether treatment is working or if the tumor is progressing, while also mapping tumor activity in the brain.
Hear when a new Pediatric Low-grade Gliomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.